Association studies of genetic variation in the WFS1 gene and type 2 diabetes in UK populations

Jayne Minton, AT Hattersley, KR Owen, MI McCarthy, M Walker, Farida Latif, Timothy Barrett, TM Frayling

    Research output: Contribution to journalArticle

    79 Citations (Scopus)


    Mutations in the WFS1 gene cause beta-cell death, resulting in a monogenic form of diabetes known as Wolfram syndrome. The role of variation in WFS1 in type 2 diabetes susceptibility is not known. We sequenced the WFS1 gene in 29 type 2 diabetic probands and identified 12 coding variants. We used 152 parent-offspring trios to look for familial association; the R allele at residue 456 (P = 0.04) and the H allele at residue 611 (P = 0.05) as well as the R456-H611 haplotype (P = 0.032) were overtransmitted to affected offspring from heterozygous parents. In a further cohort of 327 type 2 diabetic subjects and 357 normoglycemic control subjects, the H611 allele and the R456-H611 haplotype were present in more type 2 diabetic subjects than control subjects (one-tailed P = 0.06 and P = 0.023, respectively). In a combined analysis, the H611 allele was present in 60% of all diabetes chromosomes and 55% of all control chromosomes (odds ratio [OR] 1.24 [95% CI 1.03-1.48], P = 0.02), and the R456-H611 haplotype was significantly more frequent in type 2 diabetic subjects than in control subjects (60 vs. 54%, OR 1.29 [95% CI 1.08-1.54], P = 0.0053). Our results provide the first evidence that variation in the WFS1 gene may influence susceptibility to type 2 diabetes.
    Original languageEnglish
    Pages (from-to)1287-1290
    Number of pages4
    Issue number4
    Publication statusPublished - 1 Apr 2002


    Dive into the research topics of 'Association studies of genetic variation in the WFS1 gene and type 2 diabetes in UK populations'. Together they form a unique fingerprint.

    Cite this